Tumor‐Derived Peptidoglycan Recognition Protein 2 Predicts Survival and Antitumor Immune Responses in Hepatocellular Carcinoma

BACKGROUND AND AIMS: Hepatocellular carcinoma (HCC) is linked to immunosuppression. Relieving immunosuppression has been an attractive strategy to improve the efficacy of cancer immunotherapy. Peptidoglycan recognition protein 2 (PGLYRP2) is a pattern recognition receptor which is specifically expre...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Zongyi, Feng, Jia, Xiao, Li, Chen, Xi, Yao, Yuanfei, Li, Yiqun, Tang, Yu, Zhang, Shuai, Lu, Min, Qian, Yu, Wu, Hongjin, Shi, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318564/
https://www.ncbi.nlm.nih.gov/pubmed/31479523
http://dx.doi.org/10.1002/hep.30924

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318564/
https://www.ncbi.nlm.nih.gov/pubmed/31479523
http://dx.doi.org/10.1002/hep.30924

Ejemplares similares